Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment
Open Access
Abstract
Objective To compare treatment effects from randomised trials conducted in more developed versus less developed countries. Design Meta-epidemiological study. Data sources Cochrane Database of Systematic Reviews (August 2012). Data extraction Meta-analyses with mortality outcomes including data from at least one randomised trial conducted in a less developed country and one in a more developed country. Relative risk estimates of more versus less developed countries were compared by calculating the relative relative risks for each topic and the summary relative relative risks across all topics. Similar analyses were performed for the primary binary outcome of each topic. Results 139 meta-analyses with mortality outcomes were eligible. No nominally significant differences between more developed and less developed countries were found for 128 (92%) meta-analyses. However, differences were beyond chance in 11 (8%) cases, always showing more favourable treatment effects in trials from less developed countries. The summary relative relative risk was 1.12 (95% confidence interval 1.06 to 1.18; P2=0%), suggesting significantly more favourable mortality effects in trials from less developed countries. Results were similar for meta-analyses with nominally significant treatment effects for mortality (1.15), meta-analyses with recent trials (1.14), and when excluding trials from less developed countries that subsequently became more developed (1.12). For the primary binary outcomes (127 meta-analyses), 20 topics had differences in treatment effects beyond chance (more favourable in less developed countries in 15/20 cases). Conclusions Trials from less developed countries in a few cases show significantly more favourable treatment effects than trials in more developed countries and, on average, treatment effects are more favourable in less developed countries. These discrepancies may reflect biases in reporting or study design as well as genuine differences in baseline risk or treatment implementation and should be considers when generalising evidence across different settings.Keywords
This publication has 75 references indexed in Scilit:
- Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countriesThe Lancet, 2010
- Antioxidant supplements for preventing gastrointestinal cancersCochrane Database of Systematic Reviews, 2008
- Antioxidants for preventing pre-eclampsiaCochrane Database of Systematic Reviews, 2008
- Antiplatelet agents for preventing pre-eclampsia and its complicationsCochrane Database of Systematic Reviews, 2007
- A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpointsStatistics in Medicine, 2005
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- Rotavirus vaccine for preventing diarrhoeaCochrane Database of Systematic Reviews, 2004
- Oral beta-blockers for mild to moderate hypertension during pregnancyCochrane Database of Systematic Reviews, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986